AIOS Tech Inc. current report, Q1 FY2022

Business Context and Reporting Period

This Form 6-K filing by Nisun International Enterprise Development Group Co., Ltd. (the "Registrant") covers the month of February 2022, with the report dated February 9, 2022. The filing primarily addresses corporate governance changes rather than operational or financial performance.

Key Corporate Action

On January 13, 2022, the Registrant adopted an Amended and Restated Memorandum and Articles of Association ("Amended M&A"). This document was filed with the British Virgin Islands Registrar of Corporate Affairs on February 2, 2022. The amendment increases the authorized share capital to a maximum of 310,000,000 Common Shares, structured as:

  • 300,000,000 Class A Common Shares (par value $0.001 each)
  • 10,000,000 Class B Common Shares (par value $0.001 each)

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of corporate charter amendments and does not contain financial statements or operational data.

Material Changes

The material change disclosed is the increase in the authorized number of Class A and Class B common shares. There is no information provided regarding changes in financial performance compared to prior periods.

Guidance, Outlook, and Risks

The filing does not contain management commentary, financial guidance, or specific risk factors related to operations. The document notes that the summary of the Amended M&A is qualified by reference to the full text filed as Exhibit 3.1 and is incorporated by reference into the Registrant's registration statements on Form F-3.

Investor Verification Checklist

  • Verify the full text of the Amended and Restated Memorandum and Articles of Association (Exhibit 3.1) for specific rights attached to Class A and Class B shares.
  • Confirm the current outstanding share count to understand the dilution potential of the newly authorized shares.
  • Review subsequent filings for any actual issuance of shares under the new authorization.
  • Check the Form F-3 registration statement (No. 333-256550) for how this amendment impacts future capital raising capabilities.